Topic: Prevention - Primary Care
Tuesday, 21 November 2017
GP practices have a central role in the prevention of stroke. This review assessed the adequacy of primary and secondary preventive interventions that were provided for patients who were on the stroke register between January 2009 to December 2012, in the six months before and after a stroke. Eight GP practices in a deprived locality of North London participated in the review.
Wednesday, 21 February 2018
Atrial fibrillation (AF) is the commonest sustained cardiac dysrhythmia, but is asymptomatic in about one quarter of patients. Case finding with subsequent assessment of the risk of stroke and bleeding are essential to ensure that the right patients receive appropriate intervention with oral anticoagulation.
Wednesday, 13 December 2017
An 18-year UK study in more than 24,000 subjects shows the benefits of exercise in elderly patients. The EPIC Norfolk prospective population study showed that any physical activity in the elderly is better than none at all for reducing cardiovascular risk.
Wednesday, 12 September 2018
The large randomised controlled ASCEND trial (n=15,480) shows that aspirin reduced the risk of serious vascular events in people with diabetes and no CVD by 12% but also increased the risk of major bleeding by 29% and the authors concluded that absolute benefits were outweighed by bleeding hazard. The trial suggests that aspirin should not be used for primary prevention in patients with diabetes
Friday, 23 February 2018
This useful wall chart shows how just 5-10% weight loss improves important markers of cardiovascular health, including lipids, blood pressure, diabetes risk and inflammation.
Category: Back to Basics
Thursday, 02 February 2017
A French observational study has found that use of a beta-blocker early after myocardial infarction (MI) (within 48 hours) is associated with a substantial reduction in 30-day mortality in people who do not have heart failure. However, continuing with beta-blockers was not associated with a significant reduction in mortality at 1 year.
Thursday, 18 April 2019
As many as 16 million people in the UK are estimated to have hypertension, and around 7 million of these are undiagnosed. Of those diagnosed in England, one third are not receiving optimum management. Poor detection and management of hypertension places a significant burden on the NHS, and hypertension-related conditions cost an estimated £2 billion a year. We can change this by raising awareness of the consequences of hypertension, making it simpler to diagnose, and by supporting patients to manage their own health. The benefits of doing this are huge – just a 15% increase in the number of adults in England who have had their hypertension diagnosed would add 7,000 qualityadjusted life years and reduce health and social care costs by £120 m over ten years.
Wednesday, 21 February 2018
In the first 15 months of its operation, Bradford’s Healthy Hearts campaign has significantly improved the cardiovascular health of local people, and saved an estimated £1.2 m for the clinical commissioning group.
Tuesday, 03 October 2017
Anti-inflammatory injections lower the risk of cardiovascular disease in patients with previous myocardial infarction independently of lowering lipid levels, in a recent study reported in the New England Journal of Medicine.
Thursday, 22 February 2018
Category: Themed Issues